| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00016 | 1 |